|
buntanetap/posiphen Clinical Trials
2 actively recruiting trials across 2 locations
Pipeline
Phase 3: 1Phase 2/3: 1
Top Sponsors
- Annovis Bio Inc.2
Indications
- Early Alzheimers Disease1
- Parkinson's Disease (PD)1
- Deep Brain Stimulation1
- Alzheimer's Disease1
- Parkinson's Disease1
Birmingham, Alabama1 trial
A Study of Buntanetap in Participants With PD
University of Alabama at Birmingham
Phase 2/3
Chandler, Arizona1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.